Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?
Gyre Therapeutics Ownership Summary
Gyre Therapeutics is owned by 3.74% institutional investors, 86.33% insiders, and 9.93% retail investors. Vanguard group is the largest institutional shareholder, holding 1.35% of GYRE shares.
GYRE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Gyre Therapeutics | 3.74% | 86.33% | 9.93% |
| Sector | Healthcare Stocks | 35.34% | 11.88% | 52.77% |
| Industry | Biotech Stocks | 35.37% | 11.83% | 52.80% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.20M | 1.35% | $8.48M |
| Blackrock funding, inc. /de | 758.63K | 0.83% | $5.29M |
| Geode capital management | 431.41K | 0.47% | $3.01M |
| State street | 216.33K | 0.24% | $1.51M |
| Sbi securities | 170.84K | 0.19% | $1.19M |
| Charles schwab investment management | 165.24K | 0.18% | $1.15M |
| Vanguard fiduciary trust | 137.68K | 0.15% | $959.64K |
| Northern trust | 133.84K | 0.15% | $932.87K |
| Goldman sachs group | 73.12K | 0.08% | $509.66K |
| Bank of new york mellon | 43.14K | 0.05% | $300.71K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sbi securities | 170.84K | 0.03% | $1.19M |
| Tower research capital llc (trc) | 5.76K | 0.00% | $40.17K |
| Brevan howard capital management lp | 13.81K | 0.00% | $96.24K |
| Activest wealth management | 533.00 | 0.00% | $3.71K |
| Strs ohio | 21.10K | 0.00% | $147.07K |
| State of alaska, department of revenue | 5.22K | 0.00% | $36.00K |
| Geode capital management | 431.41K | 0.00% | $3.01M |
| Charles schwab investment management | 165.24K | 0.00% | $1.15M |
| Eversource wealth advisors | 163.00 | 0.00% | $4.99K |
| Vanguard fiduciary trust | 137.68K | 0.00% | $959.64K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard fiduciary trust | 137.68K | 0.00% | 137.68K |
| Vanguard group | 1.20M | 0.00% | 51.03K |
| Goldman sachs group | 73.12K | 0.00% | 42.01K |
| Blackrock funding, inc. /de | 758.63K | 0.00% | 38.34K |
| Dimensional fund advisors lp | 25.27K | - | 14.37K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 8.64K | - | -45.86K |
| State of wisconsin investment board | - | - | -24.80K |
| Nuveen | - | - | -17.59K |
| Barclays | 2.30K | - | -16.23K |
| Advantage alpha capital partners lp | - | - | -13.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 137.68K | 0.00% | 137.68K | $959.64K |
| Brevan howard capital management lp | 13.81K | 0.00% | 13.81K | $96.24K |
| Vanguard global advisers | 9.98K | - | 9.98K | $69.58K |
| Allworth financial lp | 721.00 | - | 721.00 | $5.03K |
| Eversource wealth advisors | 163.00 | 0.00% | 163.00 | $4.99K |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -6.00 |
| Rise advisors | -54.00 |
| Srs capital advisors | -57.00 |
| Federation des caisses desjardins du quebec | -75.00 |
| Principal securities | -85.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 54 | 25.58% | 3,407,279 | 1.87% | 3 | 26.54% | 31 | 24.00% | 11 | 37.50% |
| Dec 31, 2025 | 10 | -78.26% | 1,417,139 | -54.22% | 1 | 13.18% | 3 | -87.50% | 3 | -78.57% |
| Sep 30, 2025 | 15 | -65.12% | 1,514,519 | -54.84% | 1 | 12.00% | 6 | -80.65% | 5 | -28.57% |
| Jun 30, 2025 | 46 | 4.55% | 3,409,780 | 30.67% | 3 | 41.97% | 34 | 47.83% | 7 | -50.00% |
| Mar 31, 2025 | 44 | 15.79% | 2,609,380 | 57.10% | 3 | 80.28% | 23 | 15.00% | 14 | 55.56% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 18, 2026 | Ye Weiguo | Chief Operating Officer | Sell | $1.32K |
| May 19, 2026 | Ye Weiguo | Chief Operating Officer | Sell | $58.09K |
| May 14, 2026 | Ye Weiguo | Chief Operating Officer | Sell | $107.66K |
| May 15, 2026 | Ye Weiguo | Chief Operating Officer | Sell | $87.11K |
| May 05, 2026 | Luo Ying | Chief Executive Officer | Sell | $1.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 6 |
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 12 |
| 2025 Q1 | - | 59 |
GYRE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools